Estimates Revisions Cytosorbents Corporation
Stocks
CTSO
US23283X3052
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 6.370 USD | +0.63% |
|
-17.01% | -50.17% |
| 08-06 | Cytosorbents Corporation, Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CTSO Stock
- Consensus Cytosorbents Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
